Poliovirus containment is a key objective of the World Health Organization’s (WHO) Global Polio Eradication Initiative. The U.S. National Authority for Containment of Poliovirus (NAC) helps reduce the risk of polioviruses being released from the places where they are worked with or stored. The NAC is responsible for implementing the containment plan in the U.S.
U.S. National Authority for Containment of Poliovirus (NAC) policies and guidance outline containment requirements for poliovirus-essential facility (PEF) programs to possess wild type poliovirus (WPV), vaccine-derived poliovirus (VDPV), and oral polio vaccine (OPV) infectious (IM) and potentially infectious (PIM) materials.
The U.S. NAC partners with biosafety, emergency response, occupational health, security, and poliovirus subject matter experts to create policies that balance PEF work practices with containment requirements. U.S. NAC policies are based on WHO’s Global Action Plan, 3rd Edition (GAPIII) as well as all applicable U.S. regulations and guidance.
If you have any of the materials listed below, please contact UK Biosafety for guidance.
For more information, go to the CDC U.S. National Authority for Containment of Poliovirus page HERE.